Long-term efficacy of α-interferon in β-thalassemics with chronic hepatitis C

Blood

Volumn 90, Issue 6, 1997, Pages 2207-2212

  Di Marco, V ^a   Lo Iacono, O ^b   Almasio, P ^b   Ciaccio, C ^b   Capra, M ^b   Rizzo, M ^b   Malizia, R ^b   Maggio, A ^b   Fabiano, C ^b   Barbaria, F ^b   Craxi A ^b  

^a Istituto di Clinica Medica   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FERRITIN; IRON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LIVER BIOPSY; LIVER CIRRHOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; SIDEROSIS; SUBCUTANEOUS DRUG ADMINISTRATION; THALASSEMIA MAJOR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; IRON; LIVER; MALE; MULTIVARIATE ANALYSIS; SIDEROSIS; TIME FACTORS;

EID: 1842376278     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Lai ME, De Virgilis S, Argiolu F, Farci P, Mazzoleni AP, Lisci V, Rapicetta M, Clemente MG, Nurchis P, Arnone M, Balistreri A, Cao A: Evaluation of antibodies to hepatitis C virus in a long-term prospective study of post-transfusion hepatitis among thalassemic children: Comparison between first and second-generation assay. J Pediatr Gastroenterol Nutrition 16:458, 1993
2. Resti M, Azzari C, Rossi ME, Vullo C, Zammarchi E, Vierucci A: Hepatitis C virus antibodies in a long-term follow-up of beta-thalassaemic children with acute and chronic non-A, non-B hepatitis. Eur J Pediatr 151:573, 1992
3. Angelucci E: Antibodies to hepatitis C virus in thalassemia. Haematologica 79:353, 1994
4. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, Allen CJ, Farrell DE, Harris JW: Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 331:567, 1994
5. Oliveri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koreon G, Cohen AR: Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 331:574, 1994
6. Tinè F, Magrin S, Craxì A, Pagliaro L: Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials. J Hepatol 13:192, 1991
7. Pagliaro L, Craxí A, Cammá C, Tiné F, Di Marco V, Lo Iacono O, Almasio P: Interferon-α for chronic hepatitis C: An analysis of pretreatment clinical predictors of response. Hepatology 19:820, 1994
8. Magrin S, Craxì A, Fabiano C, Simonetti RG, Fiorentino G, Marino L, Diquattro O, Di Marco V, Loiacono O, Volpes R, Almasio P, Urdea MS, Neuwald P, Sanchez-Pescador R, Detmer J, Wilber JC, Pagliaro L: Hepatitis C viremia in chronic liver disease: Relationship to interferon-α or corticosteroid treatment. Hepatology 19:273, 1994
9. Chemello L, Alberti A, Rose K, Simmonds P: Hepatitis C serotype and response to interferon therapy. N Engl J Med 330:143, 1994
10. Van Thiel DH, Friedlander L, Fagiuoli S, Wright HI, Irish W, Gavaler JS: Response to interferon a therapy is influenced by the iron content of the liver. J Hepatol 20:410, 1994
11. Olynyk JK, Reddy KR, Di Bisceglie AM, Jeffers LJ, Parker TI, Radick JL, Schiff ER, Bacon BR: Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 108:1104, 1995
12. Girelli CM, Mirata C, Lesinigo E: Iron overload and response to alpha-interferon in chronic hepatitis C. Am J Gastroenterol 90:170, 1995
13. Barton AL, Banner BF, Cable EE, Bonkovsky HL: Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol 103:419, 1995
14. Ikura Y, Morimoto H, Johmura H, Fukui M, Sakurai M: Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. Am J Gastroenterol 91:1367, 1996
15. Izumi N, Enomoto N, Uchihara M, Murakami T, Ono K, Noguchi O, Miyake S, Nouchi T, Fujisawa K, Marumo F, Sato C: Hepatic iron contents and response to interferon-α in patients with chronic hepatitis C - Relationship to genotypes of hepatitis C virus. Digestive Dis Sci 41:989, 1996
16. Donohue SM, Wonke B, Hoffbrand AV, Reittie J, Ganeshaguru K, Scheuer PJ, Brown D, Dusheiko G: Alpha interferon in the treatment of chronic hepatitis C infection in thalassaemia major. Br J Haematol 83:491, 1993
17. Di Marco V, Lo Iacono O, Capra M, Grutta S, Ciaccio C, Gerardi C, Maggio A, Renda D, Almasio P, Pisa R, Craxì A: α-Interferon treatment of chronic hepatitis C in young patients with homozygous β-thalassemia. Haematologica 77:502, 1992
18. Clemente MG, Congia M, Lai ME, Lilliu F, Lampis R, Frau F, Frau MR, Faa G, Diana G, Dessì C, Melis A, Mazzoleni AP, Cornacchia G, Cao A, De Virgiliis S: Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C. J Pediatr 125:123, 1994
19. Damen M, Cuypers HTM, Zaaijer HL, Reesink HW, Schaasberg WP, Gerlich WH, Niesters HGM, Lelie PN: International collaborative study on the second EUROHEP HCV-RNA reference panel. J Virol Methods 58:175, 1996
20. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G: Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 74:1093, 1993
21. Simmonds P, Holmes EC, Cha T-A, Chan S-W, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391, 1993
22. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1513, 1994
23. Brissot P, Bourel M, Herry D, Verger JP, Messner M, Beaumont C, Regnouard F, Ferrand B, Simon M: Assessment of liver iron content in 271 patients: A reevalutation of direct and indirect methods. Gastroenterology 80:557, 1981
24. Bassett ML, Halliday JW, Powell LW: Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 6:24, 1986
25. Bacon BR, Britton RS: The pathology of hepatic iron overload: A free radical-mediated process? Hepatology 11:125, 1990
26. Farinati F, Cardin R, De Maria N, Delia Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R: Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 22:449, 1995
27. Parkkila S, Niemela O, Britton RS, Brown KE, Ylä-Herttuala S, O'Neill R, Bacon BR: Vitamin E decreases hepatic levels of aldehyde-derived peroxidation products in rats with iron overload. Am J Physiol Gastrointestinal Liver Physiol 270:G376, 1996
28. Piperno A, Fargion S, D'Alba R, Roffi L, Fracanzani AL, Vecchi L, Failla M, Fiorelli G: Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection. J Hepatol 16:364, 1992
29. Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, Di Gregorio F, Burattini MG, Terzoli S: Survival and causes of death in thalassaemia major. Lancet 2:27, 1989
30. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, Politi P, Durazzi SMT, Muretto P, Albertini F: Bone marrow trasplantation in patients with thalassemia. N Engl J Med 322:417, 1990
31. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, Andreani M, Agostinelli F, Albertini F, Clift RA: Marrow trasplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med 329:840, 1993
32. Di Marco V, Lo Iacono O, Cammà C, Almasio PL, Vaccaro A, Fuschi P, Giunta M, Fabiano C, Pagliaro L, Craxì A: A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C. J Med Virol 51:17, 1997
33. Preston H, Wright TL: Interferon therapy for chronic hepatitis C. Lancet 348:973, 1996
34. Simmonds P, Mellor J, Craxi A, Sanchez-Tapias JM, Alberti A, Prieto J, Colombo M, Rumi MG, Lo Iacano O, Ampurdanes-Mingall S, Forns-Bernhardt X, Chemello L, Civeira MP, Frost C, Dusheiko G: Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. J Hepatol 24:517, 1996
35. Lau JYN, Davis GL, Prescott LE, Maertens G, Lindsay KL, Qian KP, Mizokami M, Simmonds P, Perrillo RP, Schiff ER, Bodenheimer HC, Balart LA, Regenstein F, Dienstag JL, Katkov WN, Tamburro CH, Goff JS, Everson GT, Goodman Z, Albrecht J: Distribution of hepatitis C virus genotypes determined by line probe assay inpatients with chronic hepatitis C seen at tertiary referral centers in the United States. Ann Intern Med 124:868, 1996
36. Magrin S, Craxì A, Fabiano C, Marino L, Fiorentino G, Lo Iacono O, Volpes R, Di Marco V, Almasio P, Vaccaro A, Urdea MS, Wilber JC, Bonura C, Gianguzza F, Capursi V, Filiberti S, Stuyver L, Pagliaro L: HCV viraemia is more important than genotype as a predictor of response to interferon in Sicily (Southern Italy). J Hepatol 25:583, 1996